Centre of Evidence Based Dermatology
  • Print

CEBD Coronavirus Dermatology Resource

 

Back to CEBD Coronavirus Dermatology Resource Homepage 

 

What's new

12/8/20

[Are there cutaneous manifestations of SARS-CoV-2?].
Drerup KA, Gläser R.
Hautarzt. 2020 Aug 10. doi: 10.1007/s00105-020-04666-4. Online ahead of print. Summary of previously published review. German.
https://doi.org/10.1007/s00105-020-04666-4

Maculopapular eruptions associated to COVID-19: a subanalysis of the COVID-Piel study.
Català A, Galván-Casas C, Carretero-Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa A, Navarro-Fernández Í, Ruiz-Villaverde R, Falkenhain-López D, Llamas-Velasco M, Carnero-Gonzalez L, García-Gavin J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras I, Selda-Enriquez G, Fustà-Novell X, Roncero-Riesco M, Burgos-Blasco P, Romaní J, Solà-Ortigosa J, García-Doval I.
Dermatol Ther. 2020 Aug 10. doi: 10.1111/dth.14170. Online ahead of print. Cross-sectional study sub-analysis.
https://doi.org/10.1111/dth.14170

Re facial aesthetic injections in clinical practice: Pretreatment and post-treatment consensus recommendations to minimise adverse outcome Region-specific changes in line with the Covid-19 pandemic.
Goodman GJ, Liew S, Callan P, Hart S, Somia N, Sullivan J, Heydenrych I.
Australas J Dermatol. 2020 Aug 10. doi: 10.1111/ajd.13374. Online ahead of print. Commentary / recommendations.
https://doi.org/10.1111/ajd.13374

COVID-19 and Vitamin D: A lesson from the skin.
Slominski RM, Stefan J, Athar M, Holick MF, Jetten AM, Raman C, Slominski AT.
Exp Dermatol. 2020 Aug 11. doi: 10.1111/exd.14170. Online ahead of print. Commentary / hypothesis.
https://doi.org/10.1111/exd.14170

 

11/8/20

Dermatological manifestations in patients with SARS-CoV-2: A systematic review.
Almutairi A, Alfaleh M, Alasheikh M.
Cureus. 2020 Jul 28;12(7):e9446. doi: 10.7759/cureus.9446. Systematic review.
https://doi.org/10.7759/cureus.9446

Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist.
Martinez-Lopez A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva A, Arias-Santiago S.
J Am Acad Dermatol. 2020 Aug 7:S0190-9622(20)32358-6. doi: 10.1016/j.jaad.2020.08.006. Online ahead of print. Review.
https://doi.org/10.1016/j.jaad.2020.08.006

Urticaria and COVID-19 infection: a critical appraisal.
Pathania YS.
J Dermatolog Treat. 2020 Aug 8:1-4. doi: 10.1080/09546634.2020.1808155. Online ahead of print. Commentary.
https://doi.org/10.1080/09546634.2020.1808155

Reticular skin eruption as the initial sign of coronavirus disease 2019 infection.
Strom MA, Trager MH, Geskin LJ.
JAAD Case Rep. 2020 Jun 24;6(8):790-792. doi: 10.1016/j.jdcr.2020.06.032. eCollection 2020 Aug. Case report.
https://doi.org/10.1016/j.jdcr.2020.06.032

Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries.
Gadarowski MB, Balogh EA, Bashyam AM, Feldman SR.
J Dermatolog Treat. 2020 Aug 8:1-17. doi: 10.1080/09546634.2020.1808154. Online ahead of print. Review.
https://doi.org/10.1080/09546634.2020.1808154

Intralesional antigen immunotherapy for warts in the era of COVID-19.
Nofal A, Fawzy MM, Abdelmaksoud A, El-Hawary EE.
J Dermatolog Treat. 2020 Aug 8:1-4. doi: 10.1080/09546634.2020.1808152. Online ahead of print. Commentary / recommendations.
https://doi.org/10.1080/09546634.2020.1808152

Response to "Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment".
Shaw KS, Karagounis TK, Yin L, Gibbon G, Betensky RA, Lo Sicco KI, Femia AN.
J Am Acad Dermatol. 2020 Aug 7:S0190-9622(20)32360-4. doi: 10.1016/j.jaad.2020.07.120. Online ahead of print. Case review / audit.
https://doi.org/10.1016/j.jaad.2020.07.120

 

10/8/20

Oral symptoms and lesions in SARS-CoV-2 positive patient.
Glavina A, Biočina-Lukenda D, Mravak-Stipetić M, Markeljević J.
Oral Dis. 2020 Aug 9. doi: 10.1111/odi.13596. Online ahead of print. Case report.
https://doi.org/10.1111/odi.13596

Androgen sensitivity in COVID-19 and antiandrogens: prospective data are still needed.
Ianhez M, Ramos PM, Goren A, Miot HA.
Dermatol Ther. 2020 Aug 9:e14166. doi: 10.1111/dth.14166. Online ahead of print. Survey / cross-sectional study.
https://doi.org/10.1111/dth.14166

 

9/8/20

Cutaneous, skin histopathological manifestations and relationship to COVID-19 infection patients.
Li H, Zhao Y, Zhou L, Hu J.
Dermatol Ther. 2020 Aug 8:e14157. doi: 10.1111/dth.14157. Online ahead of print. Systematic review.
https://doi.org/10.1111/dth.14157

COVID-19 and immunosuppressive therapy in dermatology.
Schwartz RA, Pradhan S, Murrell DF, Jafferany M, Olisova OY, Lomonosov KM, Lotti T, Goldust M.
Dermatol Ther. 2020 Aug 7:e14140. doi: 10.1111/dth.14140. Online ahead of print. Review / recommendations.
https://doi.org/10.1111/dth.14140

The COVID-19 outbreak negatively affects the delivery of care for patients with diabetic foot ulcers.
Liu C, You J, Zhu W, Chen Y, Li S, Zhu Y, Ji S, Wang Y, Li H, Li L, Fan S.
Diabetes Care. 2020 Aug 7:dc201581. doi: 10.2337/dc20-1581. Online ahead of print. Research study / case review.
https://doi.org/10.2337/dc20-1581

Mental distress in dermatologists during COVID-19 pandemic: Assessment and risk factors in a global, cross-sectional study.
Bhargava S, Sarkar R, Kroumpouzos G.
Dermatol Ther. 2020 Aug 8:e14161. doi: 10.1111/dth.14161. Online ahead of print. Survey.
https://doi.org/10.1111/dth.14161

 

8/8/20

Large sacral/buttocks ulcerations in the setting of coagulopathy: A case series establishing the skin as a target organ of significant damage and potential morbidity in patients with severe COVID-19.
Young S, Narang J, Kumar S, Kwizera E, Malik P, Billings SD, Ko JS, Fernandez AP.
Int Wound J. 2020 Aug 7. doi: 10.1111/iwj.13457. Online ahead of print. Case reports.
https://doi.org/10.1111/iwj.13457

Biologic drugs during COVID-19 outbreak.
Montesu MA, Biondi G, Sotgiu G, Sucato F, Satta R.
Int J Dermatol. 2020 Aug 6. doi: 10.1111/ijd.15088. Online ahead of print. Cohort study.
https://doi.org/10.1111/ijd.15088

Changing trends in dermatology practice during COVID-19 pandemic: A single tertiary center experience.
Tanacan E, Aksoy Sarac G, Emeksiz MC, Dincer Rota D, Erdogan FG.
Dermatol Ther. 2020 Aug 6:e14136. doi: 10.1111/dth.14136. Online ahead of print. Retrospective cohort study.
https://doi.org/10.1111/dth.14136

COVID-19: An opportunity to build dermatology's digital future.
Puri P, Comfere N, Pittelkow MR, Bezalel SA, Murphree DH.
Dermatol Ther. 2020 Aug 6:e14149. doi: 10.1111/dth.14149. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14149

 

7/8/20

COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, Ghoreschi K, Goebeler M, Ludwig RJ, Schäkel K, Schilling B, Schlapbach C, Stary G, von Stebut E, Steinbrink K.
J Dtsch Dermatol Ges. 2020 Aug 6. doi: 10.1111/ddg.14169. Online ahead of print. Review.
https://doi.org/10.1111/ddg.14169

Severe acute respiratory syndrome coronavirus 2 and the use of biologics in patients with psoriasis.
Ladda M, Lynde C, Fleming P.
J Cutan Med Surg. 2020 Aug 6:1203475420945234. doi: 10.1177/1203475420945234. Online ahead of print. Review.
https://doi.org/10.1177/1203475420945234

 

6/8/20

Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19.
Droesch C, Hoang M, DeSancho M, Lee EJ, Magro C, Harp J.
JAMA Dermatol. 2020 Aug 5. doi: 10.1001/jamadermatol.2020.2800. Online ahead of print. Case series.
https://doi.org/10.1001/jamadermatol.2020.2800

Skin damage prevention strategies during COVID-19: Assessing their effect on N95 mask seal integrity.
Lansang P, Orrell KA, Tran J, Chen T.
J Cutan Med Surg. 2020 Aug 5:1203475420943861. doi: 10.1177/1203475420943861. Online ahead of print. Research study.
https://doi.org/10.1177/1203475420943861

Relationship between hand hygiene and cutaneous findings during COVID19 pandemic.
Altunisik Toplu S, Altunisik N, Turkmen D, Ersoy Y.
J Cosmet Dermatol. 2020 Aug 5. doi: 10.1111/jocd.13656. Online ahead of print. Survey / cross-sectional study.
https://doi.org/10.1111/jocd.13656

Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center.
Diotallevi F, Simonetti O, Radi G, Campanati A, Brisigotti V, Tagliati C, Rizzetto G, Martina E, Offidani A.
Australas J Dermatol. 2020 Aug 5. doi: 10.1111/ajd.13414. Online ahead of print. Report / audit.
https://doi.org/10.1111/ajd.13414

 

5/8/20

Coronavirus disease 2019-related Kawasaki-like disease in an adult: A case report.
Chérif MY, de Filette JMK, André S, Kamgang P, Richert B, Clevenbergh P.
JAAD Case Rep. 2020 Jun 24;6(8):780-782. doi: 10.1016/j.jdcr.2020.06.023. eCollection 2020 Aug. Case report.
https://doi.org/10.1016/j.jdcr.2020.06.023

Transient monoarthritis and psoriatic skin lesions following COVID-19.
De Stefano L, Rossi S, Montecucco C, Bugatti S.
Ann Rheum Dis. 2020 Aug 4:annrheumdis-2020-218520. doi: 10.1136/annrheumdis-2020-218520. Online ahead of print. Case report.
https://doi.org/10.1136/annrheumdis-2020-218520

Reduction in skin cancer diagnoses in the UK during COVID-19 pandemic.
Andrew TW, Alrawi M, Lovat P.
Clin Exp Dermatol. 2020 Aug 5. doi: 10.1111/ced.14411. Online ahead of print. Research study / audit.
https://doi.org/10.1111/ced.14411

Teledermatology and hygiene practices during the COVID-19 pandemic.
Cristaudo A, Pigliacelli F, Pacifico A, Damiani G, Iacovelli P, Morrone A.
Contact Dermatitis. 2020 Aug 4. doi: 10.1111/cod.13683. Online ahead of print. Report.
https://doi.org/10.1111/cod.13683

 

4/8/20

Five common skin manifestations of COVID-19 identified.
[No authors listed]
Br J Dermatol. 2020 Jul;183(1):e16. doi: 10.1111/bjd.19204. Plain language summary.
https://doi.org/10.1111/bjd.19204

Identificadas las principales manifestaciones en la piel de la COVID-19.
[No authors listed]
Br J Dermatol. 2020 Jul;183(1):e17. doi: 10.1111/bjd.19223. Plain language summary in Spanish.
https://doi.org/10.1111/bjd.19223

Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.
Ko CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, McNiff JM.
J Cutan Pathol. 2020 Aug 3. doi: 10.1111/cup.13830. Online ahead of print. Case series & pathology study.
https://doi.org/10.1111/cup.13830

Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards?
Grabbe S, Beissert S, Enk A.
J Dtsch Dermatol Ges. 2020 Aug 2. doi: 10.1111/ddg.14194. Online ahead of print. Review.
https://doi.org/10.1111/ddg.14194

Change of dermatological practice after the COVID-19 outbreak resolves.
Gao C, Liu B, Xie Y, Wu Z.
J Dermatolog Treat. 2020 Aug 4:1-3. doi: 10.1080/09546634.2020.1799920. Online ahead of print. Retrospective study / audit.
https://doi.org/10.1080/09546634.2020.1799920

Emergency management of 2019 novel coronavirus: implications for the dermatology department.
Tao J, Song Z, Yang L, Huang C, Feng A, Man X.
Br J Dermatol. 2020 Jun;182(6):e195. doi: 10.1111/bjd.19074. Plain language summary.
https://doi.org/10.1111/bjd.19074

A survey on teledermatology (td) use and doctors' perception in times of COVID-19.
Moscarella E, Pasquali P, Cinotti E, Tognetti L, Argenziano G, Rubegni P.
J Eur Acad Dermatol Venereol. 2020 Aug 3. doi: 10.1111/jdv.16843. Online ahead of print. Survey.
https://doi.org/10.1111/jdv.16843

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
Leung AK, McMillan T, Human A, Lam JM.
Drugs Context. 2020 Jul 20;9:2020-5-8. doi: 10.7573/dic.2020-5-8. eCollection 2020. Case report.
https://doi.org/10.7573/dic.2020-5-8

 

3/8/20

Approach to chilblains during the COVID-19 pandemic.
Ladha MA, Luca N, Constantinescu C, Naert K, Ramien ML.
J Cutan Med Surg. 2020 Aug 3:1203475420937978. doi: 10.1177/1203475420937978. Online ahead of print. Review.
https://doi.org/10.1177/1203475420937978

Comment on "Cutaneous manifestations of Covid 19: A case report & a new finding from Egypt".
Abdelmaksoud A, Goldust M, Vestita M.
Dermatol Ther. 2020 Aug 2. doi: 10.1111/dth.14120. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14120

COVID-19 board: Our multidisciplinary cutaneous oncology tumor board during the coronavirus-19 pandemic.
Chow M, Jiang SIB.
Dermatol Surg. 2020 Jul 31. doi: 10.1097/DSS.0000000000002568. Online ahead of print. Report / commentary.
https://doi.org/10.1097/dss.0000000000002568

 

2/8/20

Going viral: A brief history of chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR, Jones KM.
Semin Oncol. 2020 May 23:S0093-7754(20)30051-8. doi: 10.1053/j.seminoncol.2020.05.012. Online ahead of print. Review.
https://doi.org/10.1053/j.seminoncol.2020.05.012

Polymorphic eruption of pregnancy as a possible COVID-19 manifestation.
Proietti I, Bernardini N, Tolino E, Mambrin A, Balduzzi V, Marchesiello A, Michelini S, Skroza N, Potenza C.
Dermatol Ther. 2020 Aug 1. doi: 10.1111/dth.14117. Online ahead of print. Case report.
https://doi.org/10.1111/dth.14117

Androgenetic alopecia in COVID-19: Compared to what?
Nanes BA.
J Am Acad Dermatol. 2020 Jul 28:S0190-9622(20)32302-1. doi: 10.1016/j.jaad.2020.06.1031. Online ahead of print. Commentary.
https://doi.org/10.1016/j.jaad.2020.06.1031

Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign.
Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A.
J Am Acad Dermatol. 2020 Jul 28:S0190-9622(20)32300-8. doi: 10.1016/j.jaad.2020.07.099. Online ahead of print. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.099

Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak.
Veenstra J, Buechler CR, Robinson G, Chapman S, Adelman M, Tisack A, Dimitrion P, Todter E, Kohen L, Lim HW.
J Am Acad Dermatol. 2020 Jul 28:S0190-9622(20)32290-8. doi: 10.1016/j.jaad.2020.07.089. Online ahead of print. Retrospective cohort study.
https://doi.org/10.1016/j.jaad.2020.07.089

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.
Kearns DG, Chat VS, Uppal S, Wu JJ.
J Am Acad Dermatol. 2020 Jul 28:S0190-9622(20)32287-8. doi: 10.1016/j.jaad.2020.07.086. Online ahead of print. Trial analysis / commentary.
https://doi.org/10.1016/j.jaad.2020.07.086

 

1/8/20

Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19.
Herman A, Matthews M, Mairlot M, Nobile L, Fameree L, Jacquet LM, Baeck M.
J Eur Acad Dermatol Venereol. 2020 Jul 31. doi: 10.1111/jdv.16838. Online ahead of print. Case report.
https://doi.org/10.1111/jdv.16838

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy.
Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group.
J Eur Acad Dermatol Venereol. 2020 Jul 31. doi: 10.1111/jdv.16841. Online ahead of print. Multicentre observational study.
https://doi.org/10.1111/jdv.16841

Impact of the COVID-19 pandemic on chronic inflammatory dermatoses: Mixed messages regarding the dermatologist's point of view and the patient's concerns.
Fougerousse AC, Maccari F, Reguiai Z, Begon E, Pallure V, Taïeb C, Girard C, Mery-Bossard L.
Acta Derm Venereol. 2020 Jul 31. doi: 10.2340/00015555-3610. Online ahead of print. Commentary.
https://doi.org/10.2340/00015555-3610

Melanoma and COVID-19: A narrative review focused on treatment.
Elmas ÖF, Demirbaş A, Düzayak S, Atasoy M, Türsen Ü, Lotti T.
Dermatol Ther. 2020 Jul 31. doi: 10.1111/dth.14101. Online ahead of print. Review.
https://doi.org/10.1111/dth.14101

COVID19: Challenging tissue viability in both patients and clinicians.
Worsley PR, Spratt F, Bader DL.
J Tissue Viability. 2020 Aug;29(3):153-154. doi: 10.1016/j.jtv.2020.06.003. Epub 2020 Jun 23. Commentary.
https://doi.org/10.1016/j.jtv.2020.06.003

Working from home during and after COVID-19: watch out for erythema ab igne when using laptops.
Lewis P, Wild U, Erren TC.
Br J Gen Pract. 2020 Jul 30;70(697):404. doi: 10.3399/bjgp20X712037. Print 2020 Aug. Commentary.
https://doi.org/10.3399/bjgp20x712037

 

31/7/20

Cutaneous signs in SARS CoV-2 infection: A plea for more rigorous peer-review in the time of COVID-19.
Kittler H, Tschandl P, Weninger W.
Br J Dermatol. 2020 Jul 30. doi: 10.1111/bjd.19429. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19429

Dermatologic manifestations and complications of COVID-19.
Gottlieb M, Long B.
Am J Emerg Med. 2020 Jun 6;38(9):1715-1721. doi: 10.1016/j.ajem.2020.06.011. Online ahead of print. Review.
https://doi.org/10.1016/j.ajem.2020.06.011

The show must go on. The impacts of SARS-CoV-2 pandemic on cutaneous allergology and patch testing.
Alpalhão M, Filipe P.
Eur Ann Allergy Clin Immunol. 2020 Jul 30. doi: 10.23822/EurAnnACI.1764-1489.165. Online ahead of print. Commentary.
https://doi.org/10.23822/eurannaci.1764-1489.165

 

30/7/20

A comprehensive review of cutaneous manifestations associated with COVID-19.
Rahimi H, Tehranchinia Z.
Biomed Res Int. 2020 Jul 5;2020:1236520. doi: 10.1155/2020/1236520. eCollection 2020. Review.
https://doi.org/10.1155/2020/1236520

Late-onset cutaneous manifestations in a patient with severe COVID-19 infection.
Mizutani Y, Nagai M, Tsuzuku A.
J Dermatol. 2020 Jul 28. doi: 10.1111/1346-8138.15520. Online ahead of print. Case report.
https://doi.org/10.1111/1346-8138.15520

COVID-19 and skin cancer management: French nation-wide questionnaire survey from real-life practice.
Nardin C, Puzenat E, Dalac S, Maubec E, Aubin F; GCC.
J Dermatolog Treat. 2020 Jul 29:1-6. doi: 10.1080/09546634.2020.1801972. Online ahead of print. Survey.
https://doi.org/10.1080/09546634.2020.1801972

Treatment of severe pemphigus vulgaris during COVID-19 pandemic.
Pathania YS, Bhardwaj A.
J Dermatolog Treat. 2020 Jul 29:1-4. doi: 10.1080/09546634.2020.1801971. Online ahead of print. Commentary / recommendations.
https://doi.org/10.1080/09546634.2020.1801971

Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic.
Elsaie ML, Jafferany M, Jorgaqi E.
J Dermatolog Treat. 2020 Jul 29:1-7. doi: 10.1080/09546634.2020.1800580. Online ahead of print. Commentary / review.
https://doi.org/10.1080/09546634.2020.1800580

Recommendations for dermatology office reopening in the era of COVID-19.
Arruda S, Hexsel D, Lim T, Waldorf HA, Artzi O, Choi W, Ghannam S, Gaomin H, Ho W, Puyat MC, Rossi E, Shamban A, Sattler S, Sadick N.
J Drugs Dermatol. 2020 Jul 1;19(7):e1-e9. doi: 10.36849/JDD.2020.5293. Commentary / recommendations.
https://doi.org/10.36849/jdd.2020.5293

Dermatology residency training in COVID-19 pandemic: Transition from traditional to online teaching.
Bari AU.
J Coll Physicians Surg Pak. 2020 Jun;30(6):63-66. doi: 10.29271/jcpsp.2020.Supp1.S63. Commentary.
https://doi.org/10.29271/jcpsp.2020.supp1.s63

The dermatology and aesthetic practices in the era of COVID-19.
El-Hoshy K, El-Kalioby M.
J Dermatolog Treat. 2020 Jul 29:1-5. doi: 10.1080/09546634.2020.1800566. Online ahead of print. Commentary / recommendations.
https://doi.org/10.1080/09546634.2020.1800566

Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: a systematic review.
Hadeler E, Gitlow H, Nouri K.
Arch Dermatol Res. 2020 Jul 28. doi: 10.1007/s00403-020-02110-0. Online ahead of print. Systematic review.
https://doi.org/10.1007/s00403-020-02110-0

Egyptian dermatologists attitude towards telemedicine amidst the COVID19 pandemic: A cross-sectional study.
Elsaie ML, Shehata HA, Hanafi NS, Ibrahim SM, Ibrahim HS, Abdelmaksoud A.
J Dermatolog Treat. 2020 Jul 29:1-24. doi: 10.1080/09546634.2020.1800576. Online ahead of print. Survey / cross-sectional study.
https://doi.org/10.1080/09546634.2020.1800576

 

29/7/20

Organ-specific manifestations of COVID-19 infection.
Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA.
Clin Exp Med. 2020 Jul 27. doi: 10.1007/s10238-020-00648-x. Online ahead of print. Review.
https://doi.org/10.1007/s10238-020-00648-x

Auricle perniosis as a manifestation of Covid-19 infection.
Proietti I, Tolino E, Bernardini N, Mambrin A, Balduzzi V, Marchesiello A, Michelini S, Del Borgo C, Skroza, Lichtner M, Potenza C.
Dermatol Ther. 2020 Jul 27:e14089. doi: 10.1111/dth.14089. Online ahead of print. Case report.
https://doi.org/10.1111/dth.14089

Role of music therapy in reducing the burden of dermatological diseases during COVID-19.
Murrell DF, Kroumpouzos G, Gupta A, Di Lernia V, Sadoughifar R, Goldust M.
Dermatol Ther. 2020 Jul 28. doi: 10.1111/dth.14086. Online ahead of print. Commentary / review.
https://doi.org/10.1111/dth.14086

Comments on "Does COVID -19 influence sexual behaviours?".
Nadasdy T, Clatici VG, Barinova E, Tatu AL.
Dermatol Ther. 2020 Jul 28. doi: 10.1111/dth.14083. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14083

 

28/7/20

Making the world's skin crawl: dermatologic implications of COVID-19.
Coerdt KM, Khachemoune A.
Cutis. 2020 Jun;105(6):306-308. Review / commentary.
https://www.mdedge.com/dermatology/article/223154/infectious-diseases/making-worlds-skin-crawl-dermatologic-implications

COVID-19 and implications for dermatological and allergological diseases.
Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M.
J Dtsch Dermatol Ges. 2020 Jul 27. doi: 10.1111/ddg.14195. Online ahead of print. Review.
https://doi.org/10.1111/ddg.14195

Hand eczema due to frequent hand washing in combat with COVID-19.
Pradhan S, Kroumpouzos G, Goldust M.
J Cosmet Dermatol. 2020 Jul 27. doi: 10.1111/jocd.13639. Online ahead of print. Commentary.
https://doi.org/10.1111/jocd.13639

 

27/7/20

A compendium answering 150 questions on COVID-19 and SARS-CoV-2.
Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M, Antó JM, Arcolaci A, Azkur AK, Azkur D, Beken B, Boccabella C, Bousquet J, Breiteneder H, Carvalho D, De Las Vecillas L, Diamant Z, Eguiluz-Gracia I, Eiwegger T, Eyerich S, Fokkens W, Gao YD, Hannachi F, Johnston SL, Jutel M, Karavelia A, Klimek L, Moya B, Nadeau KC, O'Hehir R, O'Mahony L, Pfaar O, Sanak M, Schwarze J, Sokolowska M, Torres MJ, van de Veen W, van Zelm MC, Wang Y, Zhang L, Jiménez-Saiz R, Akdis CA.
Allergy. 2020 Jun 14:10.1111/all.14449. doi: 10.1111/all.14449. Online ahead of print. Review.
https://doi.org/10.1111/all.14449

Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.
Moghadam P, Blum L, Ahouach B, Radjou A, Lambert C, Scanvic A, Martres P, Decalf V, Bégon E, Bachmeyer C.
Am J Med. 2020 Jul 23:S0002-9343(20)30608-2. doi: 10.1016/j.amjmed.2020.06.025. Online ahead of print. Case report.
https://doi.org/10.1016/j.amjmed.2020.06.025

COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids.
Lockey RF, Hudey SN.
Ann Allergy Asthma Immunol. 2020 Jul 22:S1081-1206(20)30510-X. doi: 10.1016/j.anai.2020.07.019. Online ahead of print. Case report.
https://doi.org/10.1016/j.anai.2020.07.019

Chilblain rash during the COVID-19 pandemic in a 13-year-old girl: Case report and review of literature on cutaneous manifestations during the COVID-19 pandemic.
Mann N, Dobson J, Llewellyn J.
Dermatological Nursing 2020. 19(2):30-34.

What the physicians should know about mast cells, dendritic cells, urticaria and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?
Criado PR, Pagliari C, Criado RFJ, Marques GF, Junior WB.
Dermatol Ther. 2020 Jul 25. doi: 10.1111/dth.14068. Online ahead of print. Review.
https://doi.org/10.1111/dth.14068

How infodemic during the COVID-19 outbreak influenced common clinical practice in an Outpatient Service of severe psoriasis.
Sacchelli L, Evangelista V, Di Altobrando A, Lacava R, Rucci P, Rosa S, Patrizi A, Bardazzi F.
Dermatol Ther. 2020 Jul 26:e14065. doi: 10.1111/dth.14065. Online ahead of print. Prospective cohort study.
https://doi.org/10.1111/dth.14065

Surgical delay and mortality for primary cutaneous melanoma.
Guhan S, Boland G, Tanabe K, Lin W, Reddy B, Hawryluk EB, Sober AJ, Tsao H.
J Am Acad Dermatol. 2020 Jul 22:S0190-9622(20)32279-9. doi: 10.1016/j.jaad.2020.07.078. Online ahead of print. Review.
https://doi.org/10.1016/j.jaad.2020.07.078

A significant reduction in the diagnosis of melanoma during the Covid-19 lockdown in a third level center in the north of Italy.
Barruscotti S, Giorgini C, Brazzelli V, Vassallo C, Michelerio A, Klersy C, Chiellino S, Tomasini CF.
Dermatol Ther. 2020 Jul 26. doi: 10.1111/dth.14074. Online ahead of print. Retrospective case review / audit.
https://doi.org/10.1111/dth.14074

Melanoma: A silver lining in the black cloud of Covid-19.
Kassir M, Podder I, Olisova OY, Lomonosov KM, Lotti T, Goldust M.
Dermatol Ther. 2020 Jul 26. doi: 10.1111/dth.14070. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14070

The virtue of 'virtual' patch testing - a case report.
Cunningham L, Ferguson FJ, White IR, Rosbotham J, McFadden JP.
Contact Dermatitis. 2020 Jul 26. doi: 10.1111/cod.13673. Online ahead of print. Case report.
https://doi.org/10.1111/cod.13673

Einfluss der Covid-19-Pandemie auf die dermatoonkologische Versorgung in Österreich.
Koelblinger P, Nguyen VA, Hoeller C, Richtig E.
J Dtsch Dermatol Ges. 2020 Jul;18(7):778-779. doi: 10.1111/ddg.14137_g. German. Commentary.
https://doi.org/10.1111/ddg.14137_g

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
Manjaly Thomas ZR, Leuppi-Taegtmeyer A, Jamiolkowski D, Steveling-Klein E, Bellutti-Enders F, Hofmeier KS, Hartmann K.
J Allergy Clin Immunol. 2020 Jul 22:S0091-6749(20)31025-3. doi: 10.1016/j.jaci.2020.07.008. Online ahead of print. Review.
https://doi.org/10.1016/j.jaci.2020.07.008

 

26/7/20

Hand Hygiene During COVID-19: Recommendations from the American Contact Dermatitis Society.
Rundle CW, Presley CL, Militello M, Barber C, Powell DL, Jacob SE, Atwater AR, Watsky KL, Yu J, Dunnick CA.
J Am Acad Dermatol. 2020 Jul 21:S0190-9622(20)32256-8. doi: 10.1016/j.jaad.2020.07.057. Online ahead of print. Guideline / review.
https://doi.org/10.1016/j.jaad.2020.07.057

Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19.
Aghazadeh N, Homayouni M, Sartori-Valinotti JC.
Int J Dermatol. 2020 Jul 25. doi: 10.1111/ijd.15047. Online ahead of print. Case report.
https://doi.org/10.1111/ijd.15047

Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?
Megna M, Fabbrocini G, Marasca C.
Int J Dermatol. 2020 Jul 25. doi: 10.1111/ijd.15059. Online ahead of print. Commentary.
https://doi.org/10.1111/ijd.15059

Male balding is a major risk factor for severe COVID-19.
Lee J, Yousaf A, Fang W, Kolodney M.
J Am Acad Dermatol. 2020 Jul 21:S0190-9622(20)32262-3. doi: 10.1016/j.jaad.2020.07.062. Online ahead of print. Cross-sectional study.
https://doi.org/10.1016/j.jaad.2020.07.062

Management of patients with Behçet's disease during the COVID-19 pandemic.
Dursun R, Temiz SA, Özer İ, Daye M, Ataseven A.
Dermatol Ther. 2020 Jul 25:e14063. doi: 10.1111/dth.14063. Online ahead of print. Retrospective cohort study.
https://doi.org/10.1111/dth.14063

How to manage high risk asymptomatic COVID-19 carriers; COVID-19 poses a huge threat to public health and to dermatology specialty as well.
Kassir M, Gupta M, Abdelmaksoud A, Goldust M.
Dermatol Ther. 2020 Jul 25:e14064. doi: 10.1111/dth.14064. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14064

Google search increase in patient self-care during COVID-19 lockdown.
Searle T, Al-Niaimi F, Ali FR.
J Am Acad Dermatol. 2020 Jul 21:S0190-9622(20)32255-6. doi: 10.1016/j.jaad.2020.06.1028. Online ahead of print. Letter / commentary.
https://doi.org/10.1016/j.jaad.2020.06.1028

Comment on "Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID-19 emergency".
De Simone P, Iorio A, Ardigò M, Silipo V, Ferrari A, Morrone A, Frascione P.
Int J Dermatol. 2020 Jul 25. doi: 10.1111/ijd.15026. Online ahead of print. Commentary.
https://doi.org/10.1111/ijd.15026

 

25/7/20

Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study.
Kiely LF, Moloney E, O'Sullivan G, Eustace JA, Gallagher J, Bourke JF.
Clin Exp Dermatol. 2020 Jul 23. doi: 10.1111/ced.14397. Online ahead of print. Cross-sectional study.
https://doi.org/10.1111/ced.14397

The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.
Pirro F, Caldarola G, Chiricozzi A, Tambone S, Mariani M, Calabrese L, D'Urso DF, De Simone C, Peris K.
J Dermatolog Treat. 2020 Jul 24:1-14. doi: 10.1080/09546634.2020.1800578. Online ahead of print. Survey / cross-sectional study.
https://doi.org/10.1080/09546634.2020.1800578

Response to- management of leprosy patients in era of covid.
Kumar B, Narang T, Dogra S.
Dermatol Ther. 2020 Jul 23:e14052. doi: 10.1111/dth.14052. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14052

 

24/7/20

Histopathological study of a broad spectrum of skin dermatoses in patients affected or highly suspected of infection by COVID-19 in the northern part of Italy: Analysis of the many faces of the viral-induced skin diseases in previous and new reported cases.
Gianotti R, Recalcati S, Fantini F, Riva C, Milani M, Dainese E, Boggio F.
Am J Dermatopathol. 2020 Aug;42(8):564-570. doi: 10.1097/DAD.0000000000001707. Case series / pathology study.
https://doi.org/10.1097/dad.0000000000001707

Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19.
Singh P, Schwartz RA.
Dermatol Ther. 2020 Jul 23. doi: 10.1111/dth.14053. Online ahead of print. Review.
https://doi.org/10.1111/dth.14053

Surgical pearl: Novel techniques of wearing ear-looped mask for reducing pressure on the ear.
Mukhtar M.
J Am Acad Dermatol. 2020 Jul 20:S0190-9622(20)32264-7. doi: 10.1016/j.jaad.2020.07.064. Online ahead of print. No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.064

Skin cancer and COVID-19.
Goldust M, Agarwal K, Podder I, Navarini AA.
Dermatol Ther. 2020 Jul 23:e14050. doi: 10.1111/dth.14050. Online ahead of print. Commentary.
https://doi.org/10.1111/dth.14050

COVID-19 infection in patients with Sézary syndrome: report of two cases.
Gonzaga Y, Batista Fontes Santos M, Silva MM, Nucci M.
Dermatol Ther. 2020 Jul 23:e14042. doi: 10.1111/dth.14042. Online ahead of print. No abstract available. Case reports.
https://doi.org/10.1111/dth.14042

Approaching the dermatology residency application process during a pandemic.
Rosman IS, Schadt CR, Samimi SS, Rosenbach M.
J Am Acad Dermatol. 2020 Jul 20:S0190-9622(20)32266-0. doi: 10.1016/j.jaad.2020.07.066. Online ahead of print. No abstract available. Commentary / recommendations.
https://doi.org/10.1016/j.jaad.2020.07.066

A Very Peculiar Practice: Dermatology in the era of Covid-19.
Walsh S, Creamer D.
Br J Dermatol. 2020 Jul 23. doi: 10.1111/bjd.19414. Online ahead of print. Commentary.
https://doi.org/10.1111/bjd.19414

Telemedicine and the COVID-19 pandemic: Are we ready to go live?
Mills EC, Savage E, Lieder J, Chiu ES.
Adv Skin Wound Care. 2020 Aug;33(8):410-417. doi: 10.1097/01.ASW.0000669916.01793.93. Review / commentary.
https://doi.org/10.1097/01.asw.0000669916.01793.93

 

23/7/20


Dermatosurgery Practice and Implications of COVID-19 Pandemic: Recommendations by IADVL SIG Dermatosurgery (IADVL Academy).
Lahiry AK, Grover C, Mubashir S, Ashique KT, Madura C, Goyal N, Talwar A, Gupta S, Gulanikar AD, Das S.
Indian Dermatol Online J. 2020 May 10;11(3):333-336. doi: 10.4103/idoj.IDOJ_237_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367579/

Lasers Use in Dermatology Practice in the Evolving COVID-19 Scenario: Recommendations by SIG Lasers (IADVL Academy).
Dhawan S, Kumari P, De A, Pall A, Pudukadan D, Romi E, Jyothy K, Selvam MD, Mrigpuri S, Shah S, Thurakkal S, Trivedi S.
Indian Dermatol Online J. 2020 May 10;11(3):337-342. doi: 10.4103/idoj.IDOJ_239_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367557/

Dermoscopy Practice during COVID-19 Pandemic: Recommendations by SIG Dermoscopy (IADVL Academy).
Jakhar D, Bhat YJ, Chatterjee M, Keshavmurthy V, Ankad BS, Jha AK, Jayasree P, Save S, Mukherjee SS, Mehta H, Udare S, Beergouder S.
Indian Dermatol Online J. 2020 May 10;11(3):343-344. doi: 10.4103/idoj.IDOJ_231_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367558/

Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy).
Rathod S, Suneetha S, Narang T, Bhardwaj A, Gupta SK, Kamoji SG, Ashwini PK, Pradhan S, Rather SP, Patnaik S, Shankar V, Jandhyala S, Rao PN, Dogra S.
Indian Dermatol Online J. 2020 May 10;11(3):345-348. doi: 10.4103/idoj.IDOJ_234_20. eCollection 2020 May-Jun. Guideline.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367564/

Urticaria in an infant with SARS-CoV-2 positivity.
Proietti I, Mambrin A, Bernardini N, Tolino E, Balduzzi V, Maddalena P, Marchesiello A, Michelini S, Volpe S, Skroza N, Potenza C.
Dermatol Ther. 2020 Jul 22:e14043. doi: 10.1111/dth.14043. Online ahead of print. Case report.
https://doi.org/10.1111/dth.14043

Dermatologists may need to pay more attention to herpes zoster during the pandemic of COVID-19.
Wang B, Guo S, Yao Y, Li Y, Zhang G.
Infect Dis (Lond). 2020 Jul 22:1-2. doi: 10.1080/23744235.2020.1797158. Online ahead of print. Commentary.
https://doi.org/10.1080/23744235.2020.1797158

COVID 19 and immunosuppressants: An opinion pool of practising dermatologists of India.
Ray A, Debata I, Agrawal I, Panda M.
Dermatol Ther. 2020 Jul 22:e14036. doi: 10.1111/dth.14036. Online ahead of print. Survey.
https://doi.org/10.1111/dth.14036

Rituximab: a safe therapeutic option during the COVID-19 pandemic?
Di Altobrando A, Patrizi A, Abbenante D, Bardazzi F.
J Dermatolog Treat. 2020 Jul 22:1-3. doi: 10.1080/09546634.2020.1800565. Online ahead of print. Cross-sectional study.
https://doi.org/10.1080/09546634.2020.1800565

High incidence of hand eczema in Danish school children following intensive hand hygiene during the COVID-19 pandemic - a nationwide questionnaire study.
Simonsen AB, Ruge IF, Quaade AS, Johansen JD, Thyssen JP, Zachariae C.
Br J Dermatol. 2020 Jul 22. doi: 10.1111/bjd.19413. Online ahead of print. Survey / cross-sectional study.
https://doi.org/10.1111/bjd.19413

The importance of pressure injury evidence during COVID-19.
Ayello EA, Sibbald RG.
Adv Skin Wound Care. 2020 Aug;33(8):399. doi: 10.1097/01.ASW.0000684272.94842.03. Editorial.
https://doi.org/10.1097/01.asw.0000684272.94842.03

Nail care for healthcare workers during COVID-19 pandemic.
Kaur I, Jakhar D, Singal A, Grover C.
Indian Dermatol Online J. 2020 May 10;11(3):449-450. doi: 10.4103/idoj.IDOJ_232_20. eCollection 2020 May-Jun. Review / commentary.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367565/

Impact of COVID-19 pandemic on dermatologists and dermatology practice.
Bhat YJ, Aslam A, Hassan I, Dogra S.
Indian Dermatol Online J. 2020 May 10;11(3):328-332. doi: 10.4103/idoj.IDOJ_180_20. eCollection 2020 May-Jun. Review / commentary.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367587/

Teledermatology with general practitioners and paediatricians during COVID-19 outbreak in Italy: preliminary data from a second level dermatology department in North-Eastern Italy.
Bergamo S, Calacione R, Fagotti S, Finizio L, Scaini M, Schiesari L, Gatti A.
Dermatol Ther. 2020 Jul 22:e14040. doi: 10.1111/dth.14040. Online ahead of print. Report / audit.
https://doi.org/10.1111/dth.14040

Teledermatology in the wake of COVID -19 scenario: An Indian perspective.
Ashique KT, Kaliyadan F.
Indian Dermatol Online J. 2020 May 10;11(3):301-306. doi: 10.4103/idoj.IDOJ_260_20. eCollection 2020 May-Jun. Review / commentary.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367559/

Hydroxychloroquine in dermatology and beyond: Recent update.
Sardana K, Sinha S, Sachdeva S.
Indian Dermatol Online J. 2020 May 10;11(3):453-464. doi: 10.4103/idoj.IDOJ_280_20. eCollection 2020 May-Jun. Review.
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7367590/

 

22/7/20

Cutaneous manifestations of Covid 19: A case report & a new finding from Egypt.
Farouk S, Sadek A.
Dermatol Ther. 2020 Jul 21. doi: 10.1111/dth.14038. Online ahead of print. No abstract available. Case report.
https://doi.org/10.1111/dth.14038

A case of severe psoriatic erythroderma with COVID-19.
Ghalamkarpour F, Pourani MR, Abdollahimajd F, Zargari O.
J Dermatolog Treat. 2020 Jul 21:1-11. doi: 10.1080/09546634.2020.1799918. Online ahead of print. Case report.
https://doi.org/10.1080/09546634.2020.1799918

Application of hydrogel patches to the upper margins of N95 respirators as a novel anti-fog measure for goggles: a prospective, self-controlled study.
Zhou N, Suo H, Alamgir M, Li Y, Yang J, Yang L, An X, Zhang Y, Lan J, Zhang L, Zhu J, Dong L, Tao J.
J Am Acad Dermatol. 2020 Jul 18:S0190-9622(20)32223-4. doi: 10.1016/j.jaad.2020.07.053. Online ahead of print. Research study.
https://doi.org/10.1016/j.jaad.2020.07.053

Atopy is predictive of a decreased need for hospitalization for COVID-19.
Keswani A, Dhana K, Rosenthal JA, Moore D, Mahdavinia M.
Ann Allergy Asthma Immunol. 2020 Jul 18:S1081-1206(20)30489-0. doi: 10.1016/j.anai.2020.07.012. Online ahead of print. Cohort study.
https://doi.org/10.1016/j.anai.2020.07.012

Hydroxychloroquine, dermatology and SARS-CoV-2: Updating an old association.
Diotallevi F, Campanati A, Radi G, Luchetti MM, Benfaremo D, Tagliati C, Simonetti O, Offidani A.
J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26322. Online ahead of print. Report / commentary.
https://doi.org/10.1002/jmv.26322

 

21/7/20

Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
Patel N, Kho J, Smith KE, Ahmed A, Van den Abbeele K, Mandal AKJ, Missouris CG. Review.
Int J Dermatol. 2020 Jul 19. doi: 10.1111/ijd.15072. Online ahead of print. No abstract available. Case report.
https://doi.org/10.1111/ijd.15072

Psoriasis and COVID-19: A narrative review with treatment considerations.
Elmas ÖF, Demirbaş A, Kutlu Ö, Bağcıer F, Metin MS, Özyurt K, Akdeniz N, Atasoy M, Türsen Ü, Lotti T.
Dermatol Ther. 2020 Jun 17:e13858. doi: 10.1111/dth.13858. Online ahead of print.
https://doi.org/10.1111/dth.13858

 

20/7/20

Lack of association between chilblains outbreak and SARS-CoV-2: histological and serological findings from a new immunoassay.
Hébert V, Duval-Modeste AB, Joly P, Lemée V, Cellier L, Jouen F, Veber B, Drouot L, Boyer O.
J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32217-9. doi: 10.1016/j.jaad.2020.07.048. [Epub ahead of print] No abstract available. Case series / pathology study.
https://doi.org/10.1016/j.jaad.2020.07.048

Covid toes: Phenomenon or epiphenomenon?
Deutsch A, Blasiak R, Keyes A, Wu J, Marmon S, Asrani F, Moy J, Russo M, McLellan BN.
J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32206-4. doi: 10.1016/j.jaad.2020.07.037. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.037

Risk assessment of outpatient dermatology practice in the setting of the Covid-19 pandemic.
Gerami P, Liszewski WJ.
J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32204-0. doi: 10.1016/j.jaad.2020.07.035. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.035

The digital divide: how Covid-19's telemedicine expansion could exacerbate disparities.
Bakhtiar M, Elbuluk N, Lipoff JB.
J Am Acad Dermatol. 2020 Jul 16. pii: S0190-9622(20)32212-X. doi: 10.1016/j.jaad.2020.07.043. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.043

Diagnostic reliability of in-person versus remote dermatology: A meta-analysis.
Bastola M, Locatis C, Fontelo P.
Telemed J E Health. 2020 Jul 8. doi: 10.1089/tmj.2020.0043. [Epub ahead of print]. Meta-analysis.
https://doi.org/10.1089/tmj.2020.0043

 

19/7/20

Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts.
Murrell DF, Lucky AW, Salas-Alanis JC, Woodley DT, Palisson F, Natsuga K, Nikolic M, Ramirez-Quizon M, Paller AS, Lara-Corrales I, Barzegar MA, Sprecher E, Has C, Laimer M, Bruckner AL, Bilgic A, Nanda A, Purvis D, Hovnanian A, Murat-Sušić S, Bauer J, Kern JS, Bodemer C, Martin LK, Mellerio J, Kowaleski C, Robertson SJ, Bruckner-Tuderman L, Pope E, Marinkovich MP, Tang JY, Su J, Uitto J, Eichenfield LF, Teng J, Aan Koh MJ, Lee SE, Khuu P, Rishel HI, Sommerlund M, Wiss K, Hsu CK, Chiu TW, Martinez AE.
J Am Acad Dermatol. 2020 Jul 15. pii: S0190-9622(20)32195-2. doi: 10.1016/j.jaad.2020.06.1023. [Epub ahead of print] No abstract available. Guideline.
https://doi.org/10.1016/j.jaad.2020.06.1023

Caution in the time of rashes and COVID-19.
Vesely MD, Perkins SH.
J Am Acad Dermatol. 2020 Jul 15. pii: S0190-9622(20)32190-3. doi: 10.1016/j.jaad.2020.07.026. [Epub ahead of print]. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.026

Prevalence of cheilitis in health care workers managing COVID-19 patients.
Singh M, Bothra A, Pawar M, Maheswari A, Tiwari A, Adhicari P.
J Am Acad Dermatol. 2020 Jul 15. pii: S0190-9622(20)32197-6. doi: 10.1016/j.jaad.2020.06.1025. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1016/j.jaad.2020.06.1025

Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
Stoff BK, Blalock TW, Swerlick RA, MacKelfresh JB, Lawley LP, Chen SC.
J Am Acad Dermatol. 2020 Jul 15. pii: S0190-9622(20)32188-5. doi: 10.1016/j.jaad.2020.07.024. [Epub ahead of print] No abstract available. Report / commentary.
https://doi.org/10.1016/j.jaad.2020.07.024

Emergency accesses in dermatology department during the Covid-19 pandemic in a referral third level center in the north of Italy.
Isoletta E, Vassallo C, Brazzelli V, Giorgini C, Tomasini CF, Sabena A, Perlini S, De Silvestri A, Barruscotti S.
Dermatol Ther. 2020 Jul 18. doi: 10.1111/dth.14027. [Epub ahead of print]. Case review.
https://doi.org/10.1111/dth.14027

Optimizing education for dermatology residents during the COVID-19 pandemic.
Patel P, Guzman AK, McLellan B, Blasiak R.
J Am Acad Dermatol. 2020 Jul 15. pii: S0190-9622(20)32193-9. doi: 10.1016/j.jaad.2020.07.029. [Epub ahead of print] No abstract available. Report / commentary.
https://doi.org/10.1016/j.jaad.2020.07.029

 

18/7/20

Management of Phototherapy Units During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Photobiology Group.
Aguilera P, Gilaberte Y, Pérez-Ferriols A, de Argila D, Aguilera J, de Galvez MV, Granados MT, Gardeazabal J, Carrascosa JM; del Grupo Español de Fotobiología.
Actas Dermosifiliogr. 2020 Jul 14. pii: S0001-7310(20)30236-2. doi: 10.1016/j.ad.2020.07.001. [Epub ahead of print] English, Spanish. No abstract available. Guideline.
https://doi.org/10.1016/j.ad.2020.07.001

The skin in the era of coronavirus pandemic.
Ring J.
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1384-1385. doi: 10.1111/jdv.16718. No abstract available. Editorial.
https://doi.org/10.1111/jdv.16718

Treatment discontinuation and rate of disease transmission in psoriasis patients on biologic therapy during the COVID-19 pandemic - A Canadian multicenter retrospective study.
Georgakopoulos JR, Mufti A, Vender R, Yeung J.
J Am Acad Dermatol. 2020 Jul 14. pii: S0190-9622(20)32185-X. doi: 10.1016/j.jaad.2020.07.021. [Epub ahead of print] No abstract available. Retrospective study / case review.
https://doi.org/10.1016/j.jaad.2020.07.021

 

17/7/20

Necrotic acral lesions and lung failure in a fatal case of COVID-19.
Tammaro A, Chello C, Sernicola A, Magri F, Adebanjo GAR, Parisella FR, Scarabello A, Pezzuto A, Ramirez-Estrada S, Rello J.
Australas J Dermatol. 2020 Jul 16. doi: 10.1111/ajd.13400. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/ajd.13400

Herpes zoster co-infection in an immunocompetent patient with COVID-19.
Saati A, Al-Husayni F, Malibari AA, Bogari AA, Alharbi M.
Cureus. 2020 Jul 4;12(7):e8998. doi: 10.7759/cureus.8998. Case report.
https://doi.org/10.7759/cureus.8998

 

16/7/20

Erythematous papular rash: A dermatological feature of COVID-19.
Sousa Gonçalves C, Reis Carreira N, Passos D, Barbosa AL, Baltazar AM, Wahnon A, Abrantes AM, Garrido PM, Ferreira T, Teixeira Silva M, Alvoeiro L.
Eur J Case Rep Intern Med. 2020 Jun 10;7(7):001768. doi: 10.12890/2020_001768. eCollection 2020. Case report.
https://doi.org/10.12890/2020_001768

Cutaneous complications secondary to haemostasis abnormalities in COVID-19 infection.
Lorenzo-Villalba N, Maouche Y, Syrovatkova A, Pham F, Chahbazian JB, Pertoldi P, Andrès E, Zulfiqar AA.
Eur J Case Rep Intern Med. 2020 Jun 12;7(7):001769. doi: 10.12890/2020_001769. eCollection 2020. Case report.
https://doi.org/10.12890/2020_001769

Immune thrombocytopenic purpura in patients with COVID-19.
Revuz S, Vernier N, Saadi L, Campagne J, Poussing S, Maurier F.
Eur J Case Rep Intern Med. 2020 Jun 9;7(7):001751. doi: 10.12890/2020_001751. eCollection 2020. Case reports.
https://doi.org/10.12890/2020_001751

Enanthem in patients with COVID-19 and skin rash.
Jimenez-Cauhe J, Ortega-Quijano D, de Perosanz-Lobo D, Burgos-Blasco P, Vañó-Galván S, Fernandez-Guarino M, Fernandez-Nieto D.
JAMA Dermatol. 2020 Jul 15. doi: 10.1001/jamadermatol.2020.2550. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1001/jamadermatol.2020.2550

Patch testing interrupted: Virtual patch test readings during the COVID-19 pandemic.
Cheng HS.
Dermatitis. 2020 Jul/Aug;31(4):e35-e36. doi: 10.1097/DER.0000000000000628. No abstract available. Report.
https://doi.org/10.1097/DER.0000000000000628

 

15/7/20

SARS-CoV-2-related chilblains.
Ladha MA, Dupuis EC.
CMAJ. 2020 Jul 13;192(28):E804. doi: 10.1503/cmaj.201348. No abstract available. Case report.
https://doi.org/10.1503/cmaj.201348

 

14/7/20

SARS-CoV-2, COVID-19, skin and immunology - what do we know so far?
Novak N, Peng WM, Naegeli MC, Galvan C, Kolm-Djamei I, Brüggen MC, Cabanillas B, Schmid-Grendelmeier P, Catala A.
Allergy. 2020 Jul 13. doi: 10.1111/all.14498. [Epub ahead of print]. Review.
https://doi.org/10.1111/all.14498

Lessons from dermatology about inflammatory responses in Covid-19.
Criado PR, Pagliari C, Carneiro FRO, Quaresma JAS.
Rev Med Virol. 2020 Jul 12:e2130. doi: 10.1002/rmv.2130. [Epub ahead of print]. Review.
https://doi.org/10.1002/rmv.2130

Are chilblains a skin expression of COVID-19 microangiopathy?
Baeck M, Herman A, Peeters C, Marot L, Hermans C.
J Thromb Haemost. 2020 Jul 13. doi: 10.1111/jth.15008. [Epub ahead of print]. Commentary.
https://doi.org/10.1111/jth.15008

Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Martín Enguix D, Salazar Nievas MDC, Martín Romero DT.
Med Clin (Barc). 2020 Jun 5. pii: S0025-7753(20)30351-1. doi: 10.1016/j.medcli.2020.05.024. [Epub ahead of print] English, Spanish. No abstract available. Case report.
https://doi.org/10.1016/j.medcli.2020.05.024

An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
Shaigany S, Gnirke M, Guttmann A, Chong H, Meehan S, Raabe V, Louie E, Solitar B, Femia A.
Lancet. 2020 Jul 10. pii: S0140-6736(20)31526-9. doi: 10.1016/S0140-6736(20)31526-9. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1016/S0140-6736(20)31526-9

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.
Vispi M, Corradin T, Peccianti C, Feci L, Casini L, Pisani C, Fabbroni S, Corsetti P, Croatto M, Pellegrino M.
Dermatol Reports. 2020 Jun 25;12(1):8642. doi: 10.4081/dr.2020.8642. eCollection 2020 Jun 25. Report / audit.
https://doi.org/10.4081/dr.2020.8642

Facial dermatoses in general population due to personal protective masks: first observations after lockdown.
Giacalone S, Minuti A, Spigariolo CB, Passoni E, Nazzaro G.
Clin Exp Dermatol. 2020 Jul 13. doi: 10.1111/ced.14376. [Epub ahead of print]. Case reports & commentary.
https://doi.org/10.1111/ced.14376

Prevention of skin damage caused by the protective equipment used to mitigate COVID-19: monthly update.
Gefen A, Ousey K.
J Wound Care. 2020 Jul 2;29(7):379. doi: 10.12968/jowc.2020.29.7.379. No abstract available. Commentary.
https://doi.org/10.12968/jowc.2020.29.7.379

Dermatological recommendations on hand hygiene in schools during the COVID-19 pandemic.
Elsner P, Fartasch M, Schliemann S.
J Dtsch Dermatol Ges. 2020 Jul 12. doi: 10.1111/ddg.14170. [Epub ahead of print] No abstract available. Commentary / recommendations.
https://doi.org/10.1111/ddg.14170

 

13/7/20

Atypical skin manifestations during immune checkpoint blockage in COVID19-infected lung cancer patients.
Rolfo C, Cardona AF, Ruiz-Patiño A, Ariza S, Zatarain-Barron L, Pino LE, Viola L, Russo A, Rojas L, Ricaurte L, Arrieta O.
J Thorac Oncol. 2020 Jul 9. pii: S1556-0864(20)30543-8. doi: 10.1016/j.jtho.2020.06.019. [Epub ahead of print]. Case reports.
https://doi.org/10.1016/j.jtho.2020.06.019

Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: is there a role for Interleukin 17?
Carugno A, Gambini DM, Raponi F, Vezzoli P, Robustelli Test E, Arosio MEG, Callegaro A, Sena P.
Dermatol Ther. 2020 Jul 12:e14011. doi: 10.1111/dth.14011. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/dth.14011

First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.
Jimenez AC, Navarrate Navarrete N, Gratacós Gómez AR, Florido López F, Garcia Rodriguez R, Elisa GT.
Contact Dermatitis. 2020 Jul 12. doi: 10.1111/cod.13657. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/cod.13657

Does COVID-19 influence sexual behaviours?
Gaspari V, Orioni G, Viviani F, Raone B, Lanzoni A, Bardazzi F.
Dermatol Ther. 2020 Jul 11:e14004. doi: 10.1111/dth.14004. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1111/dth.14004

 

12/7/20

Extrapulmonary manifestations of COVID-19.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW.
Nat Med. 2020 Jul 10. doi: 10.1038/s41591-020-0968-3. [Epub ahead of print]. Review.
https://doi.org/10.1038/s41591-020-0968-3

Indirect skin sign of COVID-19 days: striae rubrae.
Ertugrul G, Aktas H.
J Cosmet Dermatol. 2020 Jul 11. doi: 10.1111/jocd.13607. [Epub ahead of print]. Report / commentary.
https://doi.org/10.1111/jocd.13607

STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections.
Balestri R, Magnano M, Rizzoli L, Infusino SD, Urbani F, Rech G.
J Eur Acad Dermatol Venereol. 2020 Jul 11. doi: 10.1111/jdv.16808. [Epub ahead of print]. Report / audit.
https://doi.org/10.1111/jdv.16808

Dermatology and specialty rotations: COVID-19 may reemphasize the importance of internal medicine.
Goldust M, Sharma A, Murrell DF, Kazemi N, Rudnicka L, Kassir M, Navarini A, Mueller SM.
Dermatol Ther. 2020 Jul 11. doi: 10.1111/dth.13996. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1111/dth.13996

Applying to dermatology residency during the COVID-19 pandemic.
Kearns DG, Chat VS, Uppal S, Wu JJ.
J Am Acad Dermatol. 2020 Jul 8. pii: S0190-9622(20)32175-7. doi: 10.1016/j.jaad.2020.07.011. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.011

Approach to VIPs during the COVID-19 pandemic and beyond.
Kong HE, Stoff BK.
J Am Acad Dermatol. 2020 Jul 8. pii: S0190-9622(20)32176-9. doi: 10.1016/j.jaad.2020.07.012. [Epub ahead of print] No abstract available. Ethics commentary.
https://doi.org/10.1016/j.jaad.2020.07.012

Conducting inpatient dermatology consultations and maintaining resident education in the COVID-19 telemedicine era.
Hammond MI, Sharma TR, Cooper KD, Beveridge MG.
J Am Acad Dermatol. 2020 Jul 8. pii: S0190-9622(20)32172-1. doi: 10.1016/j.jaad.2020.07.008. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.07.008

Retrospective analysis of dermatological adverse events associated with hydroxychloroquine reported to the United States Food and Drug Administration.
Lipner SR, Wang Y.
J Am Acad Dermatol. 2020 Jul 8. pii: S0190-9622(20)32171-X. doi: 10.1016/j.jaad.2020.07.007. [Epub ahead of print] No abstract available. Research study.
https://doi.org/10.1016/j.jaad.2020.07.007

 

11/7/20

Dermatologists' role in the diagnosis and management of coronavirus disease 2019 coagulopathy.
Shah P, Lo Sicco K, Caplan AS, Femia AN, Zampella JG.
Am J Clin Dermatol. 2020 Jul 9. doi: 10.1007/s40257-020-00540-0. [Epub ahead of print] No abstract available. Review / commentary.
https://doi.org/10.1007/s40257-020-00540-0

Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria.
Shanshal M.
J Dermatolog Treat. 2020 Jul 10:1-10. doi: 10.1080/09546634.2020.1795062. [Epub ahead of print]. Case report & commentary.
https://doi.org/10.1080/09546634.2020.1795062

COVID-19 presenting as a viral exanthem and detected during admission prescreening in a hematopoietic cell transplant recipient.
Ahmed N, Lima M, Rohr BR, Tomlinson BK.
Hematol Transfus Cell Ther. 2020 Jun 13. pii: S2531-1379(20)30071-7. doi: 10.1016/j.htct.2020.06.002. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1016/j.htct.2020.06.002

Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
Talamonti M, Tofani L, Bianchi L, Galluzzo M.
Arch Dermatol Res. 2020 Jul 9. doi: 10.1007/s00403-020-02103-z. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1007/s00403-020-02103-z

More on Covid-19 in immune-mediated inflammatory diseases.
Naldi L, Cazzaniga S.
N Engl J Med. 2020 Jul 10;383. pii: 10.1056/NEJMc2018011#sa1. doi: 10.1056/NEJMc2018011. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1056/NEJMc2018011

International collaboration.
Goldman MP, Murrell DF, Al-Mutairi N, Arenbergerova M, Dréno B, Alhaddad M, Al-Suwaidan SN, Firooz A, van de Kerkhof PC, Feldman SR.
J Dermatolog Treat. 2020 Jul 10:1-3. doi: 10.1080/09546634.2020.1794290. [Epub ahead of print] No abstract available. Editorial.
https://doi.org/10.1080/09546634.2020.1794290

 

10/7/20

Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection.
Hassan K.
BMJ Case Rep. 2020 Jul 7;13(7). pii: e236981. doi: 10.1136/bcr-2020-236981. Case report.
https://doi.org/10.1136/bcr-2020-236981

Erythema nodosum as a cutaneous manifestation of COVID-19 infection.
Suter P, Mooser B, Pham Huu Thien HP.
BMJ Case Rep. 2020 Jul 8;13(7). pii: e236613. doi: 10.1136/bcr-2020-236613. Case report.
https://doi.org/10.1136/bcr-2020-236613

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology.
Jessica Chang TY, Pope JE.
Immunotherapy. 2020 Jul 9. doi: 10.2217/imt-2020-0153. [Epub ahead of print] No abstract available. Review / commentary.
https://doi.org/10.2217/imt-2020-0153

Patient´s perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice.
Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Polo-Rodríguez I, Piteiro-Bermejo AB, Herrero-Fernández M, Arévalo-Serrano J, Trasobares-Marugán L, Medina-Montalvo S.
J Dermatolog Treat. 2020 Jul 9:1-9. doi: 10.1080/09546634.2020.1790485. [Epub ahead of print] No abstract available. Retrospective chart review.
https://doi.org/10.1080/09546634.2020.1790485

Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas.
Okeke CAV, Shipman WD, Perry JD, Kerns ML, Okoye GA, Byrd AS.
J Dermatolog Treat. 2020 Jul 9:1-2. doi: 10.1080/09546634.2020.1781042. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1080/09546634.2020.1781042

SmartPDT®: smartphone enabled real-time dosimetry via satellite observation for daylight photodynamic therapy.
McLellan LJ, Morelli M, Simeone E, Khazova M, Ibbotson SH, Eadie E.
Photodiagnosis Photodyn Ther. 2020 Jul 6:101914. doi: 10.1016/j.pdpdt.2020.101914. [Epub ahead of print]. Validation study.
https://doi.org/10.1016/j.pdpdt.2020.101914

Angiotensin II receptors - Impact for COVID-19 severity.
Aksoy H, Karadag AS, Wollina U.
Dermatol Ther. 2020 Jul 9:e13989. doi: 10.1111/dth.13989. [Epub ahead of print]. Review.
https://doi.org/10.1111/dth.13989

 

9/7/20

Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.
Seirafianpour F, Sodagar S, Mohammad AP, Panahi P, Mozafarpoor S, Almasi S, Goodarzi A.
Dermatol Ther. 2020 Jul 8. doi: 10.1111/dth.13986. [Epub ahead of print]. Systematic review.
https://doi.org/10.1111/dth.13986

Immune checkpoint inhibition in the era of COVID-19.
Kurzhals J, Terheyden P, Langan EA.
Clin Exp Dermatol. 2020 Jul 8. doi: 10.1111/ced.14370. [Epub ahead of print]. Review.
https://doi.org/10.1111/ced.14370

Telehealth and outreach in the post COVID-19 world: The MU Show-Me ECHO program as a national model.
Edison K.Mo Med. 2020 May-Jun;117(3):214-215. No abstract available. Commentary.
https://pmlegacy.ncbi.nlm.nih.gov/pmc/articles/PMC7302041/

Sexually transmitted COVID19.
Abdelmaksoud A, Vestita M, Goldust M.
Dermatol Ther. 2020 Jul 8. doi: 10.1111/dth.13982. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1111/dth.13982

 

8/7/20

Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up.
Nahm SH, Rembielak A, Peach H, Lorigan PC; Contributing Clinicians.
Clin Oncol (R Coll Radiol). 2020 Jul 1. pii: S0936-6555(20)30273-9. doi: 10.1016/j.clon.2020.06.017. [Epub ahead of print] No abstract available. Consensus guideline.
https://doi.org/10.1016/j.clon.2020.06.017

COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J.
Am J Emerg Med. 2020 Jun 25. pii: S0735-6757(20)30542-8. doi: 10.1016/j.ajem.2020.06.053. [Epub ahead of print]. Case report.
https://doi.org/10.1016/j.ajem.2020.06.053

Young children presenting with fever and rash in the midst of SARS-CoV-2 outbreak in New York.
Wolfe DM, Nassar GN, Divya K, Krilov LR, Noor A.
Clin Pediatr (Phila). 2020 Jul 7:9922820941631. doi: 10.1177/0009922820941631. [Epub ahead of print] No abstract available. Case reports.
https://doi.org/10.1177/0009922820941631

At home dose escalation of propranolol for infantile hemangiomas during the COVID-19 pandemic.
Bassi A, Azzarelli A, Vaccaro A, Mazzatenta C.
Dermatol Ther. 2020 Jul 7:e13977. doi: 10.1111/dth.13977. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1111/dth.13977

 

7/7/20

Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on PCR and serology testing.
Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L, Cazanave C, Colin A, Kostrzewa E, Lesort C, Levy Roy A, Lombart F, Marco-Bonnet J, Monfort JB, Samimi M, Tardieu M, Wolkenstein P, Sbidian E, Beylot-Barry M; French Society of Dermatology.
Br J Dermatol. 2020 Jul 6. doi: 10.1111/bjd.19377. [Epub ahead of print]. Survey & pathology study.
https://doi.org/10.1111/bjd.19377

A probable atypical skin manifestation of COVID-19 infection.
Shahidi Dadras M, Zargari O, Abolghasemi R, Bahmanjahromi A, Abdollahimajd F.
J Dermatolog Treat. 2020 Jul 6:1-11. doi: 10.1080/09546634.2020.1791309. [Epub ahead of print]. Case report.
https://doi.org/10.1080/09546634.2020.1791309

COVID-19 related anagen effluvium.
Shanshal M.
J Dermatolog Treat. 2020 Jul 6:1-4. doi: 10.1080/09546634.2020.1792400. [Epub ahead of print]. Case report.
https://doi.org/10.1080/09546634.2020.1792400

Mental health and dermatology practice in the COVID-19 pandemic.
Lada G, Talbot PS, Bewley A, Kleyn CE.
Clin Exp Dermatol. 2020 Jul 6. doi: 10.1111/ced.14330. [Epub ahead of print] No abstract available. Editorial.
https://doi.org/10.1111/ced.14330

Potential role of IL-17 blocking agents in the treatment of severe COVID-19?
Bulat V, Situm M, Azdajic MD, Likic R.
Br J Clin Pharmacol. 2020 Jul 5. doi: 10.1111/bcp.14437. [Epub ahead of print] No abstract available. Review / commentary.
https://doi.org/10.1111/bcp.14437

 

6/7/20

Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Carrascosa JM, Pastor-Nieto MA, Ruiz-Gonzalez I, Silvestre JF, Borrego L, Gatica-Ortega ME, Gimenez-Arnau AM; en representación del, Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC).
Actas Dermosifiliogr. 2020 Jul 2. pii: S0001-7310(20)30221-0. doi: 10.1016/j.ad.2020.06.003. [Epub ahead of print] English, Spanish. Guideline.
https://doi.org/10.1016/j.ad.2020.06.003

The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries.
Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, Harp J, Takeshita J, French LE, Lim HW, Thiers BH, Hruza GJ, Fox LP.
J Am Acad Dermatol. 2020 Jul 2. pii: S0190-9622(20)32126-5. doi: 10.1016/j.jaad.2020.06.1016. [Epub ahead of print]. Registry / case series.
https://doi.org/10.1016/j.jaad.2020.06.1016

Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification.
Potekaev NN, Zhukova OV, Protsenko DN, Demina OM, Khlystova EA, Bogin V.
Int J Dermatol. 2020 Jul 3. doi: 10.1111/ijd.15030. [Epub ahead of print] No abstract available. Case reports & review.
https://doi.org/10.1111/ijd.15030

New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus.
Battesti G, El Khalifa J, Abdelhedi N, Ferre V, Bouscarat F, Picard-Dahan C, Brunet-Possenti F, Collin G, Lavaud J, Le Bozec P, Rousselot M, Tournier A, Lheure C, Couvelard A, Hacein-Bey-Abina S, Abina AM, Charpentier C, Mignot S, Nicaise P, Descamps D, Deschamps L, Descamps V.
J Am Acad Dermatol. 2020 Jul 2. pii: S0190-9622(20)32147-2. doi: 10.1016/j.jaad.2020.06.1018. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1016/j.jaad.2020.06.1018

Risk of COVID-19 in dermatologic patients on long-term immunomodulatory therapy.
Holcomb ZE, Santillan MR, Morss-Walton PC, Salian P, Her MJ, Giannotti NM, Kimball AB, Porter ML.
J Am Acad Dermatol. 2020 Jul 1. pii: S0190-9622(20)32099-5. doi: 10.1016/j.jaad.2020.06.999. [Epub ahead of print] No abstract available. Retrospective cross-sectional study.
https://doi.org/10.1016/j.jaad.2020.06.999

The risk of respiratory tract infections in psoriasis patients treated with IL-23-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic.
Syed MN, Shin DB, Wan MT, Winthrop KL, Gelfand JM.
J Am Acad Dermatol. 2020 Jul 2. pii: S0190-9622(20)32115-0. doi: 10.1016/j.jaad.2020.06.1014. [Epub ahead of print] No abstract available. Meta-analysis.
https://doi.org/10.1016/j.jaad.2020.06.1014

Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
Ghazawi FM, Lim M, Dutz JP, Kirchhof MG.
Int J Dermatol. 2020 Jul 3. doi: 10.1111/ijd.15028. [Epub ahead of print]. Review.
https://doi.org/10.1111/ijd.15028

Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era.
Azimi SZ, Firooz A, Murrell DF, Daneshpazhooh M.
Dermatol Ther. 2020 Jul 4:e13956. doi: 10.1111/dth.13956. [Epub ahead of print]. Review.
https://doi.org/10.1111/dth.13956

Cling film for mobile phone to prevent cross-infection during COVID-19 pandemic.
Sethy M, Krishna V, Srinivas CR.
J Am Acad Dermatol. 2020 Jul 1. pii: S0190-9622(20)32108-3. doi: 10.1016/j.jaad.2020.06.1008. [Epub ahead of print] No abstract available. Report / commentary.
https://doi.org/10.1016/j.jaad.2020.06.1008

The most common pediatric and adult dermatology patient complaints in a month of the COVID-19 pandemic in Turkey.
Altun E.
Dermatol Ther. 2020 Jul 4:e13972. doi: 10.1111/dth.13972. [Epub ahead of print]. Cross-sectional study / audit.
https://doi.org/10.1111/dth.13972

Research in dermatology in the COVID-19 era.
Martinez-Lopez A, Montero-Vilchez T, Arias-Santiago S.
Dermatol Ther. 2020 Jul 4:e13971. doi: 10.1111/dth.13971. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1111/dth.13971

[5/7/20 - nothing added to PubMed]

 

4/7/20

Dermoscopy features of COVID-19-related chilblains in children and adolescents.
Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A.
J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16800. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16800

Coronavirus (COVID-19) infection-induced chilblains: A brisk perieccrine inflammatory response.
Wargo JJ, Weir NM, Shamma HN.
Am J Dermatopathol. 2020 Jun 30. doi: 10.1097/DAD.0000000000001733. [Epub ahead of print]. Case report.
https://doi.org/10.1097/DAD.0000000000001733

Concurrent chilblains and retinal vasculitis in a child with COVID-19.
Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R.
J Eur Acad Dermatol Venereol. 2020 Jul 2. doi: 10.1111/jdv.16801. [Epub ahead of print]. Case report.
https://doi.org/10.1111/jdv.16801

COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy versus apremilast in North Spain.
Queiro Silva R, Armesto S, González Vela C, Naharro Fernández C, González-Gay MA.
Dermatol Ther. 2020 Jul 3:e13961. doi: 10.1111/dth.13961. [Epub ahead of print]. Case series.
https://doi.org/10.1111/dth.13961

Protecting prone positioned patients from facial pressure ulcers using prophylactic dressings: A timely biomechanical analysis in the context of the COVID-19 pandemic.
Peko L, Barakat-Johnson M, Gefen A.
Int Wound J. 2020 Jul 3. doi: 10.1111/iwj.13435. [Epub ahead of print]. Research report.
https://doi.org/10.1111/iwj.13435

Learning new ways of teaching and assessment - The impact of Covid-19 on undergraduate dermatology education.
Nic Dhonncha E, Murphy M.
Clin Exp Dermatol. 2020 Jul 3. doi: 10.1111/ced.14364. [Epub ahead of print]. Report / commentary.
https://doi.org/10.1111/ced.14364

Dermatology residents and COVID-19: life behind the frontlines.
Viviani F, Ferrari T, Mussi M, Zengarini C, Orioni G.
Clin Exp Dermatol. 2020 Jul 3. doi: 10.1111/ced.14365. [Epub ahead of print]. Report / commentary.
https://doi.org/10.1111/ced.14365

Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report.
Davoodi L, Jafarpour H, Kazeminejad A, Soleymani E, Akbari Z, Razavi A.
Oxf Med Case Reports. 2020 Jun 25;2020(6):omaa042. doi: 10.1093/omcr/omaa042. eCollection 2020 Jun. Case report.
https://doi.org/10.1093/omcr/omaa042

 

3/7/20

A viral rash: the impact of COVID-19 infection on the skin.
Hay RJ.
Br J Dermatol. 2020 Jul;183(1):1-2. doi: 10.1111/bjd.19188. No abstract available. Editorial.
https://doi.org/10.1111/bjd.19188

Chilblain-like lesions during COVID-19 pandemic: a serological study on a case series.
Rizzoli L, Collini L, Magnano M, Termine S, Barcelli R, Infusino SD, Bauer P, Rech G, Girardelli CR, Balestri R.
Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19348. [Epub ahead of print]. Case series / pathology study.
https://doi.org/10.1111/bjd.19348

No evidence of SARS-Cov-2 infection by PCR or serology in children with pseudochilblain.
Caselli D, Chironna M, Loconsole D, Nigri L, Mazzotta F, Bonamonte D, Aricò M.
Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19349. [Epub ahead of print]. Case series / pathology study.
https://doi.org/10.1111/bjd.19349

Acral purpuric lesions associated with coagulation disorders during the COVID-19 pandemic.
García-Gil MF, Monte Serrano J, García García M, Barra Borao V, Matovelle Ochoa C, Ramirez-Lluch M, Ara-Martín M.
Int J Dermatol. 2020 Jul 2. doi: 10.1111/ijd.15041. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/ijd.15041

Response to: "Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases": Vesicular eruption in COVID-19 - to exclude varicella.
Lim SYD, Tey HL.
Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19347. [Epub ahead of print]. Letter / commentary.
https://doi.org/10.1111/bjd.19347

"Vesicular eruption in COVID-19 - to exclude varicella": reply from the authors.
Català A, Galván Casas C, Carretero Hernández G, García-Doval I.
Br J Dermatol. 2020 Jul 1. doi: 10.1111/bjd.19350. [Epub ahead of print]. Author reply.
https://doi.org/10.1111/bjd.19350

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19.
Gambichler T, Reuther J, Scheel CH, Becker JC.
J Immunother Cancer. 2020 Jul;8(2). pii: e001145. doi: 10.1136/jitc-2020-001145. Review.
https://pmlegacy.ncbi.nlm.nih.gov/pubmed/32611687

Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID-19 pandemic.
Kutlu Ö.
Dermatol Ther. 2020 Jul 2:e13949. doi: 10.1111/dth.13949. [Epub ahead of print]. Google search analysis.
https://doi.org/10.1111/dth.13949

 

2/7/20

Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: Review of the literature.
Kaya G, Kaya A, Saurat JH.
Dermatopathology (Basel). 2020 Jun 30;7(1):3-16. doi: 10.3390/dermatopathology7010002. Review.
https://doi.org/10.3390/dermatopathology7010002

Acral edema during the COVID-19 pandemic.
Valtueña J, Ruiz-Sánchez D, Volo V, Manchado-López P, Garayar-Cantero M.
Int J Dermatol. 2020 Jul 1. doi: 10.1111/ijd.15025. [Epub ahead of print] No abstract available. Case reports.
https://doi.org/10.1111/ijd.15025

Facial skin temperature and discomfort when wearing protective face masks: Thermal infrared imaging evaluation and hands moving the mask.
Scarano A, Inchingolo F, Lorusso F.
Int J Environ Res Public Health. 2020 Jun 27;17(13). pii: E4624. doi: 10.3390/ijerph17134624. Research study.
https://doi.org/10.3390/ijerph17134624

Cosmetic surgeries amidst pandemic area of COVID-19: suggested protocol.
Emadi SN, Ehsani AH, Balighi K, Nasimi M.
J Dermatolog Treat. 2020 Jul 1:1-6. doi: 10.1080/09546634.2020.1790484. [Epub ahead of print] No abstract available. Commentary / recommendations.
https://doi.org/10.1080/09546634.2020.1790484

A UK-wide survey looking at teaching and trainee confidence in teledermatology: A vital gap in a Covid-19 induced era of rapid digital transformation?
Lowe A, Pararajasingam A, Goodwin R.
Clin Exp Dermatol. 2020 Jun 30. doi: 10.1111/ced.14358. [Epub ahead of print]. Survey.
https://doi.org/10.1111/ced.14358

Potential use of turmeric in COVID-19.
Gupta H, Gupta M, Bhargava S.
Clin Exp Dermatol. 2020 Jul 1. doi: 10.1111/ced.14357. [Epub ahead of print]. Commentary.
https://doi.org/10.1111/ced.14357

 

1/7/20

COVID-19 and cutaneous manifestations: A systematic review.
Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F.
J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16778. [Epub ahead of print]. Systematic review.
https://doi.org/10.1111/jdv.16778

COVID-19 and dermatology.
GÜl Ü.
Turk J Med Sci. 2020 Jun 30. doi: 10.3906/sag-2005-182. [Epub ahead of print]. Review/ commentary.
https://doi.org/10.3906/sag-2005-182

Skin manifestations in COVID-19: A case series of 5 patients from ElazıĞ, Turkey.
Bakar Dertlioğlu S.
Dermatol Ther. 2020 Jun 30:e13932. doi: 10.1111/dth.13932. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1111/dth.13932

COVID-19 lockdown induced acral dermatosis in children.
Bodak N, Chiaverini C, Barbarot S.
J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16797. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16797

COVID-19 and outbreak of chilblains: are they related?
Lesort C, Kanitakis J, Villani A, Ducroux E, Bouschon P, Fattouh K, Bensaid B, Danset M, Jullien D.
J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16779. [Epub ahead of print]. Case series.
https://doi.org/10.1111/jdv.16779

Erythematous-oedematous type of chilblain-like lesions and COVID-19 : an Indian perspective.
Das A, Singh V.
Dermatol Ther. 2020 Jun 27:e13912. doi: 10.1111/dth.13912. [Epub ahead of print] No abstract available. Case series.
https://doi.org/10.1111/dth.13912

Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
Bapst T, Romano F, Müller M, Rohr M.
BMJ Case Rep. 2020 Jun 29;13(6). pii: e236986. doi: 10.1136/bcr-2020-236986. No abstract available. Case report.
https://doi.org/10.1136/bcr-2020-236986

Herpes zoster cases increased during COVID-19 outbreak. Is it possible a relation?
Ertugrul G, Aktas H.
J Dermatolog Treat. 2020 Jun 27:1-4. doi: 10.1080/09546634.2020.1789040. [Epub ahead of print] No abstract available. Report / commentary.
https://doi.org/10.1080/09546634.2020.1789040

Herpes zoster as a potential complication of coronavirus disease 2019.
Pona A, Jiwani RA, Afriyie F, Labbe J, Cook PP, Mao Y.
Dermatol Ther. 2020 Jun 30:e13930. doi: 10.1111/dth.13930. [Epub ahead of print] No abstract available. Case report.
https://doi.org/10.1111/dth.13930

Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain.
Pastor-Nieto MA, Checa-Díaz P, González-Muñoz P, Martín-Fuentes A, Vergara-Sánchez A, Sánchez-Herreros C, Jiménez-Blázquez E, Cabana-Navia R, Martínez-Mariscal J, Cobo-Rodríguez P, Checa-Recio I, Gatica-Ortega ME, Torralba M, De Eusebio-Murillo E.
J Eur Acad Dermatol Venereol. 2020 Jun 28. doi: 10.1111/jdv.16798. [Epub ahead of print]. Cross-sectional study.
https://doi.org/10.1111/jdv.16798

Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech Republic.
Rob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J.
J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16771. [Epub ahead of print]. Prospective research study.
https://doi.org/10.1111/jdv.16771

COVID-19 and psoriasis: Biologic treatment and challenges.
Ebrahimi A, Sayad B, Rahimi Z.
J Dermatolog Treat. 2020 Jun 29:1-14. doi: 10.1080/09546634.2020.1789051. [Epub ahead of print]. Review.
https://doi.org/10.1080/09546634.2020.1789051

Treatment of psoriasis - unburdened by fear during SARS-CoV2 menace.
Timis TL, Florian IA, Vesa SC, Orasan RI.
J Dermatolog Treat. 2020 Jun 27:1-10. doi: 10.1080/09546634.2020.1788704. [Epub ahead of print]. Review / commentary.
https://doi.org/10.1080/09546634.2020.1788704

Using cyclosporine in the COVID era: an emergent need for caution.
Khurana A, Sethia K.
J Am Acad Dermatol. 2020 Jun 27. pii: S0190-9622(20)32090-9. doi: 10.1016/j.jaad.2020.06.990. [Epub ahead of print]. Commentary.
https://doi.org/10.1016/j.jaad.2020.06.990

Hand hygiene in preventing COVID-19 transmission.
Gupta MK, Lipner SR.
Cutis. 2020 May;105(5):233-234. No abstract available. Review / commentary.
https://www.mdedge.com/dermatology/article/221793/contact-dermatitis/hand-hygiene-preventing-covid-19-transmission

Global Hidradenitis Suppurativa COVID-19 Registry: A registry to inform data-driven management practices.
Naik HB, Alhusayen R, Frew J, Guilbault S, Ingram JR, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA.
Br J Dermatol. 2020 Jun 29. doi: 10.1111/bjd.19345. [Epub ahead of print]. Research letter.
https://doi.org/10.1111/bjd.19345

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms.
Galán Sánchez JL, San Nicasio CS, Olivares MG, Martín CG, Madueño KD, Martín Díaz MÁ, Tarjuelo DV, Dobao PC.
J Am Acad Dermatol. 2020 Jun 27. pii: S0190-9622(20)32086-7. doi: 10.1016/j.jaad.2020.06.986. [Epub ahead of print]. Case series.
https://doi.org/10.1016/j.jaad.2020.06.986

COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: A tele-medicine experience.
Shahidi-Dadras M, Abdollahimajd F, Ohadi L, Tabary M, Araghi F, Mozafari N, Toosi P, Dadkhahfar S.
J Dermatolog Treat. 2020 Jun 27:1-7. doi: 10.1080/09546634.2020.1789041. [Epub ahead of print]. Cross-sectional study.
https://doi.org/10.1080/09546634.2020.1789041

"Cell phone acne" epidemic during COVID-19 pandemic.
Singh M, Pawar M, Maheshwari A, Bothra A, Khunger N.
Clin Exp Dermatol. 2020 Jun 29. doi: 10.1111/ced.14360. [Epub ahead of print]. Case series.
https://doi.org/10.1111/ced.14360

Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.
Turkmen D, Altunisik N, Sener S, Colak C.
Dermatol Ther. 2020 Jun 28:e13923. doi: 10.1111/dth.13923. [Epub ahead of print]. Survey.
https://doi.org/10.1111/dth.13923

The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone.
Gironi LC, Boggio P, Giorgione R, Damiani G, Savoia P.
J Dermatolog Treat. 2020 Jun 30:1-20. doi: 10.1080/09546634.2020.1789044. [Epub ahead of print]. Retrospective observational study/ audit.
https://doi.org/10.1080/09546634.2020.1789044

Head and neck surgery is a high-risk procedure for COVID-19 transmission, and there is a need for a preventive strategy to protect professionals.
Garcia-Doval I.
J Am Acad Dermatol. 2020 May 16. pii: S0190-9622(20)30926-9. doi: 10.1016/j.jaad.2020.05.061. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.05.061

Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery.
Do MH, Minkis K, Petukhova TA, Lipner SR.
J Am Acad Dermatol. 2020 Jun 27. pii: S0190-9622(20)32083-1. doi: 10.1016/j.jaad.2020.06.983. [Epub ahead of print]. Commentary.
https://doi.org/10.1016/j.jaad.2020.06.983

The New Normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care.
Cohen JM, Bunick CG, Perkins SH.
J Am Acad Dermatol. 2020 Jun 25. pii: S0190-9622(20)31173-7. doi: 10.1016/j.jaad.2020.06.075. [Epub ahead of print] No abstract available. Report / commentary.
https://doi.org/10.1016/j.jaad.2020.06.075

Dermatological consultations in the COVID-19 era: Is teledermatology the key to social distancing? An Egyptian experience.
Mostafa PIN, Hegazy AA.
J Dermatolog Treat. 2020 Jun 30:1-20. doi: 10.1080/09546634.2020.1789046. [Epub ahead of print]. Cross-sectional observational study.
https://doi.org/10.1080/09546634.2020.1789046

Time to revisit HIPAA? Accelerated telehealth adoption during the COVID-19 pandemic.
Chinmoy B, Ho CH, Brodell RT.
J Am Acad Dermatol. 2020 Jun 27. pii: S0190-9622(20)32089-2. doi: 10.1016/j.jaad.2020.06.989. [Epub ahead of print] No abstract available. Commentary.
https://doi.org/10.1016/j.jaad.2020.06.989

Patient Perspectives: What is COVID-19?
[No authors listed]
Pediatr Dermatol. 2020 May;37(3):555-556. doi: 10.1111/pde.14218. No abstract available. Patient information.
https://doi.org/10.1111/pde.14218

 

Back to CEBD Coronavirus Dermatology Resource Homepage

Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR


telephone: +44 (0) 115 823 1048
email:cebd@nottingham.ac.uk